Loading
Life sciences · Journal article
The American Surgeon · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
BackgroundWe evaluated temporal trends in registry-coded no primary-site surgery separately for colon and rectal adenocarcinoma using SEER data from 2000 through 2023.MethodsColon and rectal adenocarcinomas were identified. The endpoint was registry-coded no primary-site surgery, which cannot distinguish planned organ preservation, refusal, inoperability, or incomplete treatment capture. Site-specific trends were evaluated using linear and piecewise logistic models. Principal analyses, including post-2018 trends, were not stage-adjusted because AJCC stage in the extract covered only 2004-2015. Survival comparisons were descriptive.ResultsThe cohort included 397 116 colon and 120 487 rectal cancers. Between 2000-2005 and 2018-2023, no primary-site surgery increased from 10.2% to 30.1% in rectal cancer and from 2.9% to 6.5% in colon cancer. Rectal cancer odds increased by 5.4% per year before 2018 and 17.5% per year after 2018. The colon trend was approximately linear, with a 4.2% annual increase in odds. A stage-adjusted analysis in the 2004-2015 stage I-III subset supported an earlier increase but could not evaluate the post-2018 acceleration.DiscussionRegistry-coded no primary-site surgery increased in both cancers, with a greater and accelerating rise in rectal cancer. These descriptive findings extend contemporary observations and support site-specific interpretation. The unadjusted post-2018 pattern cannot establish changes independent of stage or identify planned watch-and-wait, treatment refusal, or absence of cancer-directed therapy.